Works matching IS 00071048 AND DT 2024 AND VI 205 AND IP 3

Results: 59
    1
    2
    3
    4

    Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 1055, doi. 10.1111/bjh.19679
    By:
    • LeBlanc, Francis R.;
    • Breese, Erin H.;
    • Burns, Karen C.;
    • Chang, Ellen K.;
    • Jones, LaQuita M.;
    • Lee, Lynn;
    • Mizukawa, Benjamin;
    • Norris, Robin E.;
    • O'Brien, Maureen M.;
    • Phillips, Christine L.;
    • Perentesis, John P.;
    • Rubinstein, Jeremy;
    • Pommert, Lauren
    Publication type:
    Article
    5

    Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 1017, doi. 10.1111/bjh.19680
    By:
    • Hei, Zhiliang;
    • Yang, Shujun;
    • Ouyang, Guifang;
    • Hanna, Jolimar;
    • Lepoivre, Michel;
    • Huynh, Tony;
    • Aguinaga, Lorea;
    • Cassinat, Bruno;
    • Maslah, Nabih;
    • Bourge, Mickaël;
    • Golinelli‐Cohen, Marie‐Pierre;
    • Guittet, Olivier;
    • Vallières, Cindy;
    • Vernis, Laurence;
    • Fenaux, Pierre;
    • Huang, Meng‐Er
    Publication type:
    Article
    6
    7
    8
    9
    10

    Emergency myelopoiesis in solid cancers.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 798, doi. 10.1111/bjh.19656
    By:
    • Aliazis, Konstantinos;
    • Yenyuwadee, Sasitorn;
    • Phikulsod, Ployploen;
    • Boussiotis, Vassiliki A.
    Publication type:
    Article
    11
    12

    Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 1097, doi. 10.1111/bjh.19651
    By:
    • Kamijo, Kimimori;
    • Shimomura, Yoshimitsu;
    • Kim, Sung‐Won;
    • Ohigashi, Hiroyuki;
    • Ishikawa, Jun;
    • Eto, Tetsuya;
    • Hiramoto, Nobuhiro;
    • Mizuno, Ishikazu;
    • Iida, Shinsuke;
    • Ueda, Yasunori;
    • Matsuoka, Ken‐ichi;
    • Yakushijin, Kimikazu;
    • Mori, Yasuo;
    • Onizuka, Makoto;
    • Fukuda, Takahiro;
    • Atsuta, Yoshiko;
    • Kako, Shinichi
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Effect of peptide‐binding motif on survival of HLA‐haploidentical transplantation with post‐transplant cyclophosphamide.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 1077, doi. 10.1111/bjh.19630
    By:
    • Ido, Kentaro;
    • Nakamae, Hirohisa;
    • Hattori, Norimichi;
    • Kanaya, Minoru;
    • Morita, Kaoru;
    • Hino, Masayuki;
    • Ohigashi, Hiroyuki;
    • Fukuda, Takahiro;
    • Eto, Tetsuya;
    • Nagafuji, Koji;
    • Hiramoto, Nobuhiro;
    • Maruyama, Yumiko;
    • Ota, Shuichi;
    • Matsuoka, Ken‐ichi;
    • Ando, Toshihiko;
    • Akasaka, Takashi;
    • Mori, Yasuo;
    • Kamimura, Tomohiko;
    • Kawakita, Toshiro;
    • Kawamura, Koji
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    CD19‐CAR T‐cell therapy with sorafenib in post‐HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch—A case report and review of the literature.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 1215, doi. 10.1111/bjh.19608
    By:
    • Oszer, A.;
    • Kołodrubiec, J.;
    • Pawlik, B.;
    • Marschollek, P.;
    • Ćwilichowska, N.;
    • Jakubowska, J.;
    • Bukowska‐Strakova, K.;
    • Surman, M.;
    • Trelińska, J.;
    • Miarka‐Walczyk, K.;
    • Haze, N.;
    • Liszka, K.;
    • Mielcarek‐Siedziuk, M.;
    • Kałwak, K.;
    • Poręba, M.;
    • Pastorczak, A.;
    • Janczar, S.;
    • Młynarski, W.
    Publication type:
    Article
    34
    35
    36
    37
    38

    Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemia.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 1011, doi. 10.1111/bjh.19595
    By:
    • Gover‐Proaktor, Ayala;
    • Leshem‐Lev, Dorit;
    • Winograd‐Katz, Sabina;
    • Partouche, Shirly;
    • Samara, Aladin;
    • Shapira, Saar;
    • Nardi‐Agmon, Inbar;
    • Harari, Emanuel;
    • Younis, Aseel;
    • Najjar, Abderrahman;
    • Kornowski, Ran;
    • Geiger, Benjamin;
    • Raanani, Pia;
    • Leader, Avi;
    • Granot, Galit
    Publication type:
    Article
    39

    Twice‐weekly induction with ixazomib–lenalidomide–dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant‐eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014‐03

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 891, doi. 10.1111/bjh.19570
    By:
    • Perrot, Aurore;
    • Roussel, Murielle;
    • Lauwers‐Cances, Valerie;
    • Hulin, Cyrille;
    • Leleu, Xavier;
    • Touzeau, Cyrille;
    • Facon, Thierry;
    • Mariette, Clara;
    • Schiano, Jean‐Marc;
    • Gay, Julie;
    • Montes, Lydia;
    • Ranta, Dana;
    • Huguet, Amandine;
    • Wuillème, Soraya;
    • Dejoie, Thomas;
    • Devlamynck, Laure;
    • Corre, Jill;
    • Avet‐Loiseau, Hervé;
    • Moreau, Philippe;
    • Attal, Michel
    Publication type:
    Article
    40

    Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A CIBMTR analysis.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 1202, doi. 10.1111/bjh.19569
    By:
    • Epperla, Narendranath;
    • Hashmi, Hamza;
    • Ahn, Kwang W.;
    • Allbee‐Johnson, Mariam;
    • Chen, Andy I.;
    • Wirk, Baldeep;
    • Kanakry, Jennifer A.;
    • Lekakis, Lazaros;
    • Kharfan‐Dabaja, Mohamed A.;
    • Scordo, Michael;
    • Riedell, Peter A.;
    • Jain, Tania;
    • Shadman, Mazyar;
    • Sauter, Craig;
    • Hamadani, Mehdi;
    • Herrera, Alex F.;
    • Ahmed, Sairah
    Publication type:
    Article
    41
    42
    43

    Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐DICEP) versus R‐GDP

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 881, doi. 10.1111/bjh.19555
    By:
    • Stewart, Douglas A.;
    • Kuruvilla, John;
    • Lee, David;
    • Dudebout, Jill J.;
    • Chua, Neil;
    • Larouche, Jean‐François;
    • Baetz, Tara;
    • Shafey, Mona;
    • Abdel‐Samad, Nizar;
    • Robinson, Sue;
    • Fleury, Isabelle;
    • Fraser, Graeme;
    • Skrabek, Pamela;
    • Kukreti, Vishal;
    • Kelly, Jesse;
    • Hay, Annette E.;
    • Shepherd, Lois E.;
    • Chen, Bingshu E.;
    • Crump, Michael
    Publication type:
    Article
    44

    Gilteritinib with or without venetoclax for relapsed/refractory FLT3‐mutated acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 932, doi. 10.1111/bjh.19548
    By:
    • Kugler, Eitan;
    • Cohen, Inbar;
    • Amitai, Irina;
    • Ram, Ron;
    • Frisch, Avraham;
    • Nachmias, Boaz;
    • Canaani, Jonathan;
    • Moshe, Yakir;
    • Krayem, Baher;
    • Aumann, Shlomzion;
    • Henig, Israel;
    • Vainstein, Vladimir;
    • Shargian, Liat;
    • Ganzel, Chezi;
    • Yeshurun, Moshe;
    • Levi, Itay;
    • Raanani, Pia;
    • Akria, Luiza;
    • Ofran, Yishai;
    • Shimony, Shai
    Publication type:
    Article
    45

    Inflammatory profile of lower risk myelodysplastic syndromes.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 1044, doi. 10.1111/bjh.19530
    By:
    • Topping, Joanne;
    • Taylor, Adele;
    • Nadat, Fatima;
    • Crouch, Simon;
    • Ibbotson, Alice;
    • Čermák, Jaroslav;
    • Symeonidis, Argiris;
    • Tatic, Aurelia;
    • Langemeijer, Saskia;
    • Hellström‐Lindberg, Eva;
    • Culligan, Dominic;
    • Garelius, Hege Gravdahl;
    • Ashcroft, John;
    • Nga, Emma;
    • Parker, Jane;
    • Kolade, Seye;
    • McDermott, Michael F.;
    • De Witte, Theo;
    • Bowen, David;
    • Smith, Alexandra
    Publication type:
    Article
    46
    47
    48

    Changes in T‐cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T‐cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 999, doi. 10.1111/bjh.19515
    By:
    • Zhou, Xiang;
    • Wagner, Vivien;
    • Scheller, Lukas;
    • Stanojkovska, Emilia;
    • Riedhammer, Christine;
    • Xiao, Xianghui;
    • Steinhardt, Maximilian Johannes;
    • Vogt, Cornelia;
    • Nerreter, Silvia;
    • Eisele, Florian;
    • John, Mara;
    • Munawar, Umair;
    • Kadel, Sofie‐Katrin;
    • Mersi, Julia;
    • Ruckdeschel, Anna;
    • Schimanski, Sven;
    • Haertle, Larissa;
    • Waldschmidt, Johannes Moritz;
    • Han, Seungbin;
    • Topp, Max
    Publication type:
    Article
    49
    50

    French early nationwide idecabtagene vicleucel chimeric antigen receptor T‐cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real‐world IFM study from the DESCAR‐T registry.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 990, doi. 10.1111/bjh.19505
    By:
    • Ferment, B.;
    • Lambert, J.;
    • Caillot, D.;
    • Lafon, I.;
    • Karlin, L.;
    • Lazareth, A.;
    • Touzeau, C.;
    • Leleu, X.;
    • Moya, N.;
    • Harel, S.;
    • Perrot, A.;
    • Bories, P.;
    • Vincent, L.;
    • Lamure, S.;
    • Mohty, M.;
    • Malard, F.;
    • Manier, S.;
    • Yakoub‐Agha, I.;
    • Schiano De Colella, J.‐M.;
    • Brisou, G.
    Publication type:
    Article